Ascentage Pharma Group International (NASDAQ:AAPG – Get Free Report) gapped up before the market opened on Friday . The stock had previously closed at $19.67, but opened at $20.80. Ascentage Pharma Group International shares last traded at $21.20, with a volume of 39,891 shares.
Ascentage Pharma Group International Trading Up 5.8 %
About Ascentage Pharma Group International
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
Featured Stories
- Five stocks we like better than Ascentage Pharma Group International
- There Are Different Types of Stock To Invest In
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- 5 Top Rated Dividend Stocks to Consider
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- Low PE Growth Stocks: Unlocking Investment Opportunities
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
